RT Journal Article
SR Electronic
T1 Genetic mismatch explains sizable variation of COVID-19 vaccine efficacy in clinical trials
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.22.21254079
DO 10.1101/2021.04.22.21254079
A1 Cao, Lirong
A1 Zhao, Shi
A1 Lou, Jingzhi
A1 Zheng, Hong
A1 Pun Mok, Chris Ka
A1 Chan, Renee WY
A1 Chong, Marc Ka Chun
A1 Chen, Zigui
A1 Chan, Paul KS
A1 Zee, Benny Chung-Ying
A1 Wang, Maggie Haitian
YR 2021
UL http://medrxiv.org/content/early/2021/04/22/2021.04.22.21254079.abstract
AB Pulling vaccine efficacy and effectiveness (VE) outcomes from 17 reports of 9 different vaccine products and through sequence analysis, we found that genetic mismatch explained sizable variations in VE. The findings suggested the potential need of timely optimizing vaccine antigens as new dominant viral strains emerge.Competing Interest StatementM.H.W and B.C.Y.Z are shareholders of Beth Bioinformatics Co., Ltd. B.C.Y.Z is a shareholder of Health View Bioanalytics Ltd. All other authors declare no competing interests.Funding StatementThis work was supported by the National Natural Science Foundation of China [31871340, 71974165], the Hong Kong Health and Medical Research Fund [INF-CUHK-1], and the Chinese University of Hong Kong Direct Grant [4054456, 4054524].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethical approval or individual consent was not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in this work are publicly available.